María Andrés‐Rozas
19 works · 213 citations · h-index 5
Top works
- Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease
- Hepatocyte-derived extracellular vesicles promote endothelial dedifferentiation in chronic liver disease through the miR-153-3p-pyroptosis axis
- Sinusoidal communication in chronic liver disease
- Sex-specific differences in preclinical models of advanced chronic liver disease and portal hypertension
- Development and characterization of a cell donor registry for virus‐specific T cell manufacture in a blood bank
- GTX-11 improves portal hypertension, liver fibrosis, and sinusoidal cells phenotype in experimental MASH
- GTX-011 improves fibrosis and hepatic stellate cells phenotype in human precision cut liver slices
- Beyond GLP-1R: Dynamic Glucagon Receptor Family Signalling May Determine Antifibrotic Responses to Incretin-Based Therapies.
- Beyond GLP ‐ 1R : Dynamic Glucagon Receptor Family Signalling May Determine Antifibrotic Responses to Incretin‐Based Therapies
- Human leukocyte antigen genotype modulates cytomegalovirus- and Epstein–Barr virus-specific T-cell response in healthy donors for optimized virus-specific T-cell donor selection
- UN MODELO MICROFLUÍDICO DE TEJIDO CIRRÓTICO HUMANO REVELA LA CAPACIDAD ANTIFIBRÓTICA DE LIRAGLUTIDA MEDIANTE LA DESACTIVACIÓN DE LAS CÉLULAS HEPÁTICAS ESTRELLADAS Y EL REMODELADO DE LA MATRIZ EXTRACELULAR
- FRI-421 GLP-1 agonist lowers portal pressure by modulating hepatic vascular tone in a toxin-induced cirrhotic rat model
- THU-132 Hepatocyte derived extracellular vesicles promote endothelial dedifferentiation in chronic liver disease through the miR-153-3p – pyroptosis axis
- TOP-296-YI Liver-specific CNNM4 silencing alleviates fibrosis by restoring bile acids homeostasis in cholestatic preclinical models and human liver slices
- THU-176 Sex-specific differences in preclinical models of advanced chronic liver disease and portal hypertension
- Microfluidic human liver slices reveal antifibrotic effects of liraglutide via HSC deactivation and ECM remodeling